ATARA BIOTHERAPEUTICS, INC.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2016 | $-12.5M | $-13.4M | $891.0K | $4.7M |
| Jun 2016 | $-10.8M | $-11.5M | $748.0K | — |
| Sep 2016 | $-15.6M | $-16.0M | $386.0K | — |
| Mar 2017 | $-22.0M | $-23.2M | $1.2M | $5.3M |
| Jun 2017 | $-20.3M | $-23.4M | $3.1M | — |
| Sep 2017 | $-20.2M | $-26.4M | $6.2M | — |
| Mar 2018 | $-34.8M | $-54.6M | $19.8M | $7.0M |
| Jun 2018 | $-39.4M | $-46.9M | $7.4M | — |
| Sep 2018 | $-48.1M | $-52.6M | $4.5M | — |
| Mar 2019 | $-70.2M | $-71.0M | $796.0K | $12.3M |
| Jun 2019 | $-54.6M | $-55.3M | $738.0K | — |
| Sep 2019 | $-52.1M | $-53.6M | $1.5M | — |
| Mar 2020 | $-67.0M | $-68.4M | $1.3M | $12.6M |
| Jun 2020 | $-56.6M | $-58.7M | $2.1M | — |
| Sep 2020 | $-53.0M | $-53.5M | $503.0K | — |
| Mar 2021 | $-65.7M | $-67.9M | $2.2M | $12.3M |
| Jun 2021 | $-61.6M | $-63.6M | $2.1M | — |
| Sep 2021 | $-59.0M | $-62.8M | $3.9M | — |
| Mar 2022 | $-84.5M | $-87.1M | $2.6M | $14.3M |
| Jun 2022 | $-64.0M | $-65.4M | $1.4M | — |
| Sep 2022 | $-65.1M | $-65.2M | $132.0K | — |
| Mar 2023 | $-38.4M | $-38.8M | $399.0K | $11.8M |
| Jun 2023 | $-52.8M | $-53.3M | $499.0K | — |
| Sep 2023 | $-51.3M | $-51.6M | $281.0K | — |
| Mar 2024 | $-29.6M | $-29.7M | $127.0K | $8.4M |
| Jun 2024 | $-10.6M | $-10.7M | $29.0K | — |
| Sep 2024 | $-4.0M | $-4.0M | $0 | — |
| Mar 2025 | $-28.1M | $-28.1M | $0 | $4.2M |
| Jun 2025 | $-7.3M | $-7.3M | $0 | — |
| Sep 2025 | $-9.8M | $-9.8M | $0 | — |